CXR Biosciences: your partner in preclinical problem solving

At CXR, we use our extensive industry experience and understanding of biological mechanisms to deliver tailored preclinical services:

• Investigative and Mechanistic Toxicology: By understanding the pathways that define the sensitivity of cells to chemicals, we evaluate the actual hazard to man, and rescue chemicals and drugs that may otherwise be abandoned.

• Exploratory & Discovery Toxicology: In order to improve productivity, CXR can help you shift the identification of potential toxic hazard and risk from the development stage to the research stage of R&D.

• Drug Development Solutions: Accelerating lead selection and optimisation via in vitro and in vivo preclinical studies.

• Novel Technologies: Commercialising innovative preclinical tools which allow improved safety and DMPK prediction in man.